Key result
Prehypertension was associated with an increased risk of chronic kidney disease compared to optimal blood pressure (RR 1.28; 95% CI 1.13-1.44; P=0.000).
Why the study?
Does prehypertension increase the incidence of chronic kidney disease compared to optimal blood pressure?
Meta-Analysis (n=261,264)
Yes
Does prehypertension increase the incidence of chronic kidney disease compared to optimal blood pressure?
Relative Risk: 1.28 (95% CI 1.13–1.44)
p-value: p=0.000
Prehypertension is associated with a significantly increased risk of developing chronic kidney disease, particularly in women and East Asian populations.
Prehypertension may warrant closer CKD monitoring in women and East Asians; leaves causal role and intervention effects open for prospective trials.
BACKGROUND: Recent studies have demonstrated that there is an association between prehypertension and an increased risk of end-stage renal disease. However, there is conflicting evidence regarding the relationship between prehypertension and chronic kidney disease (CKD). This meta-analysis aimed to demonstrate the association between prehypertension and the incidence of CKD and identify the impacts of gender and ethnic differences. METHODS: MEDLINE, EMBASE, Cochrane Library (from inception through March 2016) and article reference lists were searched for relevant studies regarding blood pressure and CKD. Blood pressure (BP) measurements were classified as follows: optimal BP (less than 120/80 mmHg), prehypertension (120-139/80-89 mmHg) and hypertension (over 140/90 mmHg). CKD was defined by estimated glomerular filtration rate (eGFR)<60 ml/min/1.73 m2 or proteinuria. Two investigators independently extracted the data and assessed the quality of studies enrolled in this meta-analysis using the Newcastle-Ottawa Scale (NOS). We performed the meta-analysis using Stata/SE 12.0 (StataCorp LP). The random-effect models were used in the heterogeneous analyses. RESULTS: After retrieving data from 4,537 potentially relevant articles, we identified 7 cohort studies including 261,264 subjects, according to the predefined selection criteria. Five studies were conducted in Mongolians from East Asia, and the other two studies were performed in Indo-Europeans from Austria and Iran. The participants ranged in age from 20 to 89 years, and the proportion of females ranged from 27.2% to 63.8%. The follow-up period ranged from 2 to 11 years. Compared with the optimal BP values, prehypertension showed an increased risk of CKD (pooled RR = 1.28; 95% CI = 1.13-1.44; P = 0.000; I2 = 77.9%). In the sex-stratified analysis, we found a similar trend in women (pooled RR = 1.29; 95% CI = 1.01-1.63; P = 0.039; I2 = 76.1%) but not in men. This effect was observed only in Mongolians from East Asia (pooled RR = 1.37; 95% CI = 1.18-1.59; P = 0.000; I2 = 81.3%) and not in Indo-Europeans. CONCLUSIONS: Prehypertension is considered a potential cause of CKD. Gender and ethnic differences are exhibited in this association.
No takes yet. Share an insight, caveat, or question.
Li et al. (2016) conducted a meta-analysis in Chronic Kidney Disease (n=261,264). Prehypertension vs. Optimal blood pressure (<120/80 mmHg) was evaluated on Incidence of chronic kidney disease (CKD) (RR 1.28, 95% CI 1.13-1.44, p=0.000). Prehypertension was associated with an increased risk of chronic kidney disease compared to optimal blood pressure (RR 1.28; 95% CI 1.13-1.44; P=0.000).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: